Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP [Phase 3]

View source ↗

Summary

Phase III trial evaluating intravenous nemonoxacin for community-acquired pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Nemonoxacin (Nemonoxacin)

Snippet

Sponsor: TaiGen Biotechnology Co., Ltd. | Conditions: Community-acquired Pneumonia | Phase 3 | Status: COMPLETED